Komlossy Law, P.A. Announces Investigation of Conceptus, Inc.
30 April 2013 - 9:24PM
Business Wire
Komlossy Law, P.A. is investigating the Board of Directors of
Conceptus, Inc. (“Conceptus” or the “Company”) (Nasdaq:CPTS) for
possible breaches of fiduciary duty and other violations of state
law in connection with their attempt to complete a sale of the
Company to Bayer HealthCare LLC in a transaction valued at
approximately $1.1 billion. Pursuant to the terms of the proposed
transaction, Conceptus shareholders are to receive $31.00 in cash
for each share.
The investigation involves whether the Board of Directors of
Conceptus breached their fiduciary duties to stockholders by
favoring the interests of certain officers and directors of the
Company in the proposed acquisition, and whether the transaction is
fair to shareholders with respect to price, process and disclosure
of all material information.
If you own Conceptus stock and wish to obtain additional
information about your rights as a shareholder, or if you have
information about the above investigation, please contact Emily C.
Komlossy, Esq. via email at eck@komlossylaw.com or Ross A. Appel,
Esq. at raa@komlossylaw.com or by telephone toll free at (855)
858-1233.
Komlossy Law, P.A. represents shareholders in complex
litigation, including class action and derivative litigation.
Komlossy Law, P.A. may co-counsel with another firm, or refer a
case to another firm. More information is available through its
website, www.komlossylaw.com/CPTS, and upon request from the firm.
Emily C. Komlossy is the attorney responsible for the content of
this release.
Attorney Advertisement. Past results do not guarantee or predict
a similar outcome with respect to any future matter.
Conceptus, Inc. (MM) (NASDAQ:CPTS)
Historical Stock Chart
Von Aug 2024 bis Sep 2024
Conceptus, Inc. (MM) (NASDAQ:CPTS)
Historical Stock Chart
Von Sep 2023 bis Sep 2024
Echtzeit-Nachrichten über Conceptus, Inc. (MM) (NASDAQ): 0 Nachrichtenartikel
Weitere Komlossy Law, P.A. News-Artikel